Order Article Reprints

Battista T, Pascarella G, Staid DS, Colotti G, Rosati J, Fiorillo A, Casamassa A, Vescovi AL, Giabbai B, Semrau MS, et al. Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. International Journal of Molecular Sciences. 2021; 22(3):1293. https://doi.org/10.3390/ijms22031293

Battista, Theo, Gianmarco Pascarella, David Sasah Staid, Gianni Colotti, Jessica Rosati, Annarita Fiorillo, Alessia Casamassa, Angelo Luigi Vescovi, Barbara Giabbai, Marta Stefania Semrau, and et al. 2021. "Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells" International Journal of Molecular Sciences 22, no. 3: 1293. https://doi.org/10.3390/ijms22031293

Battista, T., Pascarella, G., Staid, D. S., Colotti, G., Rosati, J., Fiorillo, A., Casamassa, A., Vescovi, A. L., Giabbai, B., Semrau, M. S., Fanelli, S., Storici, P., Squitieri, F., Morea, V., & Ilari, A. (2021). Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. International Journal of Molecular Sciences, 22(3), 1293. https://doi.org/10.3390/ijms22031293